<Record><identifier xmlns="http://purl.org/dc/elements/1.1/">URN:NBN:SI:doc-C1NROSH7</identifier><date>2007</date><creator>Kos, Janko</creator><creator>Obermajer, Nataša</creator><creator>Vozelj, Suzana</creator><relation>documents/znanstveni_clanki/farmacevtski_vestnik/html/urn_nbn_si_doc-c1nrosh7.html</relation><relation>documents/znanstveni_clanki/farmacevtski_vestnik/pdf/urn_nbn_si_doc-c1nrosh7.pdf</relation><relation>documents/znanstveni_clanki/farmacevtski_vestnik/txt/urn_nbn_si_doc-c1nrosh7.txt</relation><format format_type="issue">4</format><format format_type="volume">58</format><format format_type="main">6 strani</format><format format_type="type">article</format><format format_type="extent">str. 133-138</format><identifier identifier_type="ISSN">0014-8229</identifier><identifier identifier_type="COBISSID">2230385</identifier><identifier identifier_type="URN">URN:NBN:SI:doc-C1NROSH7</identifier><language>slv</language><publisher>Slovensko farmacevtsko društvo</publisher><source>Farmacevtski vestnik</source><rights>InC</rights><subject language_type_id="slv">kazalci</subject><subject language_type_id="slv">laboratorijska diagnostika</subject><subject language_type_id="slv">proteaze</subject><subject language_type_id="slv">rak (medicina)</subject><title>Proteaze in njihovi inhibitorji v telesnih tekočinah kot diagnostični in prognostični tumorski kazalci</title></Record>